Cisplatin safety data sheet
WebOct 6, 2014 · SAFETY DATA SHEET Creation Date 06-Oct-2014 Revision Date 24-Dec-2024 Revision Number 5 1. Identification Product Name cis-Dichlorodiamineplatinum(II) … WebSAFETY DATA SHEET Product Name: Cisplatin Injection 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION Manufacturers Name And Address Hospira, Inc. Hospira …
Cisplatin safety data sheet
Did you know?
WebApr 8, 2024 · Cisplatin - Safety Data Sheet Chemical Safety Data Sheet MSDS / SDS Cisplatin Revision Date:2024-03-18 Revision Number:1 SECTION 1: Identification of the … WebSafety Data Sheet Revision Number: 3 Date Issued 12-Jan-2024 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERSTANDING 1.1 Product identifier Product Name: RIABNI™ (rituximab-arrx) Common Name: RIABNI™ (rituximab-arrx) Chemical Name: anti-CD20 monoclonal antibody Synonyms: ABP 798
WebApr 13, 2010 · SAFETY DATA SHEET Creation Date 13-Apr-2010 Revision Date 24-Dec-2024 Revision Number 5 1. Identification Product Name 5-Azacytidine Cat No. : AC226620000; AC226620010; AC226620500 CAS No 320-67-2 Synonyms 4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazine-2(1H)-one Recommended Use Laboratory chemicals. … WebCisplatin - CAS 15663-27-1, is a platinum coordination complex with potent anti-neoplastic activity. Induces apoptosis in cancer cells, possibly via caspase-3 activation. Cisplatin - CAS 15663-27-1 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents. SDS CoA References Data Sheet
WebSAFETY DATA SHEET Revision date 22-Jan-2024 Version 1 Page 1 / 8 Section 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier Product Name RUXIENCE for injection Product Code(s) PF00010 Synonyms Rituximab; Rituximab-pvvr Trade Name: Ruxience; … WebSAFETY DATA SHEET Revision Date 18-Feb-2024 Revision Number 2 1. Identification Product Name Bortezomib Cat No. : J60378 CAS-No 179324-69-7 Synonyms No information available Recommended Use Laboratory chemicals. Uses advised against Food, drug, pesticide or biocidal product use. Details of the supplier of the safety data sheet
WebMigration and invasion enhancer 1 (MIEN1/C35/C17orf37), as an oncogenic gene, is located on chromosome 17q12 and 505 nucleotides from the 3′ end of the ERBB2 oncogene [1,2].Several studies have shown that MIEN1 overexpression results in either disease progression or metastatic propensity in many tumor types, including colon, prostate, …
WebSDS Manager offers a free online service available to everyone, where you can find and download Safety Data Sheets for your business. Our online SDS service is always available to you. Millions of Safety Data Sheets 25 languages SDSs are available in PDF format, and can be downloaded for free from our server SDS DATABASE SDS SHEET MSDS & PSDS florian wittkopWebCisplatin is commonly used in combination therapy with the following cytotoxic agents: 1. For the treatment of testicular cancer: vinblastine, bleomycin, actinomycin D. 2. For … florian wittlingerWebCisplatin for injection has been administered at 75 mg/m. 2 . to 100 mg/m. intravenously per cycle once every 3 to 4 weeks on Day 1. Other doses and combination regimens have … great team spirit imagesWebMATERIAL SAFETY DATA SHEET _____ Material Name: Cisplatin Solution for Injection - 0.5 and 1 mg/ml Revision date: 02-Jan-2007 Page 2 of 7 Version: 1.1 EU Hazard … great team traductionWeb· Details of the supplier of the safety data sheet · Manufacturer/Supplier: Cayman Chemical Co. 1180 E. Ellsworth Rd. Ann Arbor, MI 48108 USA · Information department: Product safety department · Emergency telephone number: During normal opening times: +1 (734) 971-3335 US/CANADA: 800-424-9300 Outside US/CANADA: 703-741-5970 2 Hazard(s ... great team videosWebMaterial Safety Data Sheet of Cisplatin AbMole BioScience Safety Data Sheet 1. PRODUCT AND COMPANY IDENTIFICATION 2. HAZARDS IDENTIFICATION 3. COMPOSITION/INFORMATION ON INGREDIENTS 4. FIRST AID MEASURES 5. FIRE FIGHTING MEASURES 6. ACCIDENTAL RELEASE MEASURES 7. HANDLING AND … great team start with greatWeba The safety and pharmacokinetics of irinotecan given once-every-3-weeks have not been defined in patients with bilirubin >3.0 x institutional upper limit of normal (IULN) and this schedule cannot be recommended in these patients. ... Irinotecan in Combination with Cisplatin. Irinotecan has been studied in combination with cisplatin for non ... great team success